{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:18:02Z","timestamp":1787170682623,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Direcci\u00f3n General de Investigaci\u00f3n of Spain","award":["CTQ2011-28417-C02-01"],"award-info":[{"award-number":["CTQ2011-28417-C02-01"]}]},{"name":"Direcci\u00f3n General de Investigaci\u00f3n of Spain","award":["CEI10\/00018"],"award-info":[{"award-number":["CEI10\/00018"]}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"crossref","award":["P11-CVI-7427"],"award-info":[{"award-number":["P11-CVI-7427"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"crossref","award":["FQM134"],"award-info":[{"award-number":["FQM134"]}],"id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"crossref"}]},{"name":"EU Research Potential","award":["FP7-REGPOT-2012-CT2012-31637-IMBRAIN"],"award-info":[{"award-number":["FP7-REGPOT-2012-CT2012-31637-IMBRAIN"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ejmech.2016.07.021","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T02:05:52Z","timestamp":1468634752000},"page":"155-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Selenoureido-iminosugars: A new family of multitarget drugs"],"prefix":"10.1016","volume":"123","author":[{"given":"Jacob Ingemar","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela B.","family":"Plata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Padr\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d3scar","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Bols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 G.","family":"Fern\u00e1ndez-Bola\u00f1os","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2016.07.021_bib1a","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-385518-3.00004-3","article-title":"Imino sugars and glycosyl hydrolases: historical context, current aspects, emerging trends","volume":"66","author":"St\u00fctz","year":"2011","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib1b","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1039\/B915870G","article-title":"Glycosidase inhibition: assessing mimicry of the transition state","volume":"8","author":"Gloster","year":"2010","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib1c","series-title":"Comprehensive Glycoscience-from Chemistry to Systems Biology","first-page":"815","article-title":"Glycosidase inhibitors: structure, activity, synthesis, and medical relevance","author":"Bols","year":"2007"},{"key":"10.1016\/j.ejmech.2016.07.021_bib1d","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1021\/cr000433k","article-title":"Recent developments of transition-state analogue glycosidase inhibitors of non-natural product origin","volume":"102","author":"Lillelund","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2016.07.021_bib2","first-page":"215","article-title":"Glycosidase inhibitors: versatile tools in glycobiology","volume":"38","author":"L\u00f3pez","year":"2012"},{"key":"10.1016\/j.ejmech.2016.07.021_bib3","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.4155\/fmc.11.117","article-title":"Iminosugars as therapeutic agents: recent advances and promising trends","volume":"3","author":"Nash","year":"2011","journal-title":"Fut. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10719-010-9278-1","article-title":"Lysosomal storage of oligosaccharide and glycosphingolipid in imino sugar treated cells","volume":"27","author":"Boomkamp","year":"2010","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.ejmech.2016.07.021_bib5","doi-asserted-by":"crossref","first-page":"9096","DOI":"10.1021\/jm501181z","article-title":"Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase\/neutral glucosylceramidase inhibitors","volume":"57","author":"Ghisaidoobe","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.antiviral.2013.06.011","article-title":"Antiviral therapies targeting host ER alpha-glucosidases: current status and future directions","volume":"99","author":"Chang","year":"2013","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2016.07.021_bib7","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1039\/c2ob25727k","article-title":"Iminosugar\u2013ferrocene conjugates as potential anticancer agents","volume":"10","author":"Hottin","year":"2012","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib8","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/asia.201400023","article-title":"N-Arylated-lactam-type iminosugars as new immunosuppressive agents: discovery, optimization, and biological evaluation","volume":"9","author":"Wu","year":"2014","journal-title":"Chem.-Asian J."},{"key":"10.1016\/j.ejmech.2016.07.021_bib9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1271\/nogeikagaku1924.50.11_571","article-title":"The structure of moranoline, a piperidine alkaloid from Morus species","volume":"50","author":"Yagi","year":"1976","journal-title":"Nippon. Nogei Kagaku Kaishi"},{"key":"10.1016\/j.ejmech.2016.07.021_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0957-4166(99)00468-1","article-title":"Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis","volume":"11","author":"Butters","year":"2000","journal-title":"Tetrahedron Asymmetry"},{"key":"10.1016\/j.ejmech.2016.07.021_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.2217\/14750708.2.4.569","article-title":"Miglustat: substrate reduction therapy for glycosphingolipid storage disorders","volume":"2","author":"Lachmann","year":"2005","journal-title":"Therapy"},{"key":"10.1016\/j.ejmech.2016.07.021_bib12","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/ml100192b","article-title":"Identification of potent and selective glucosylceramide synthase inhibitors from a library of N-alkylated iminosugars","volume":"2","author":"Ghisaidoobe","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.07.021_bib13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.2174\/0929867323666160210130608","article-title":"Role of nanotechnology for enzyme replacement therapy in lysosomal diseases. a focus on Gaucher's disease","volume":"23","author":"Mart\u00edn-Banderas","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bcmd.2005.05.007","article-title":"Miglustat (NB-DNJ) works as a chaperone for mutated acid \u03b2-glucosidase in cells transfected with several Gaucher disease mutations","volume":"35","author":"Alfonso","year":"2005","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.ejmech.2016.07.021_bib15","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2147\/TCRM.S6865","article-title":"Review of miglustat for clinical management in Gaucher disease type 1","volume":"4","author":"Ficicioglu","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ejmech.2016.07.021_bib16","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1021\/mp200313e","article-title":"Therapeutic strategies for Gaucher disease: miglustat (NB-DNJ) as a pharmacological chaperone for glucocerebrosidase and the different thermostability of velaglucerase alfa and imiglucerase","volume":"8","author":"Abian","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2016.07.021_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pneurobio.2014.12.001","article-title":"Gaucher-related synucleinopathies: the examination of sporadic neurodegeneration from a rare (disease) angle","volume":"125","author":"Sardi","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2016.07.021_bib18","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2174\/138955708785740652","article-title":"From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of Alzheimer's disease","volume":"8","author":"Bolognesi","year":"2008","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/18715273113126660166","article-title":"Current acetylcholinesterase-inhibitors: a neuroinformatics perspective","volume":"13","author":"Shaikh","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.ejmech.2016.07.021_bib20","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/cbic.200700012","article-title":"Anomer-selective glycosidase inhibition by 2-N-alkylated 1-azafagomines","volume":"8","author":"L\u00f3pez L\u00f3pez","year":"2007","journal-title":"ChemBioChem"},{"key":"10.1016\/j.ejmech.2016.07.021_bib21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cbi.2010.01.042","article-title":"Acetylcholinesterase: from 3D structure to function","volume":"187","author":"Dvir","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2016.07.021_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.bioorg.2015.12.002","article-title":"Synthesis and anti-acetylcholinesterase activity of scopoletin derivatives","volume":"65","author":"Khunnawutmanotham","year":"2016","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fnmol.2011.00019","article-title":"Interactions of AChE with A\u03b2 aggregates in Alzheimer's brain: therapeutic relevance of IDN 5706","volume":"4","author":"Carvajal","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2016.07.021_bib24","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1007\/s12035-015-9337-5","article-title":"Oxidative stress in neurodegenerative diseases","volume":"53","author":"Niedzielska","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejmech.2016.07.021_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.bbrc.2011.08.080","article-title":"Protective effect of catechin in type I Gaucher disease cells by reducing endoplasmic reticulum stress","volume":"413","author":"Lee","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2016.07.021_bib26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/jo061280p","article-title":"Development of adamantan-1-yl-methoxy-functionalized 1-deoxynojirimycin derivatives as selective inhibitors of glucosylceramide metabolism in man","volume":"72","author":"Wennekes","year":"2007","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1055\/s-1999-3430","article-title":"Synthesis of 1-deoxynojirimycin and N-butyl-1-deoxynojirimycin","author":"Matos","year":"1999","journal-title":"Synthesis"},{"key":"10.1016\/j.ejmech.2016.07.021_bib28","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/j.tet.2009.01.038","article-title":"Synthesis of sugar-derived isoselenocyanates, selenoureas, and selenazoles","volume":"65","author":"L\u00f3pez","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2016.07.021_bib29","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1021\/bi9522514","article-title":"Evaluation of isofagomine and its derivatives as potent glycosidase inhibitors","volume":"35","author":"Dong","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2016.07.021_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3233\/JAD-140219","article-title":"Cholinesterase inhibition in Alzheimer's disease: is specificity the answer?","volume":"42","author":"Macdonald","year":"2014","journal-title":"J.\u00a0Alzheimer Dis."},{"key":"10.1016\/j.ejmech.2016.07.021_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1570159X11311030006","article-title":"Acetylcholinesterase inhibitors: pharmacology and toxicology","volume":"11","author":"\u010colovi\u0107","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.ejmech.2016.07.021_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.bmcl.2014.12.071","article-title":"Iminosugars as a new class of cholinesterase inhibitors","volume":"25","author":"Decroocq","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2016.07.021_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.06.011","article-title":"Selenocysteine oxidation in glutathione peroxidase catalysis: an MS-supported quantum mechanics study","volume":"87","author":"Orian","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2016.07.021_bib34","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.bmc.2015.02.048","article-title":"In\u00a0vitro radical scavenging and cytotoxic activities of novel hybrid selenocarbamates","volume":"23","author":"Romano","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2016.07.021_bib35","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1021\/ja00085a040","article-title":"A\u00a0model study on the effect of an amino group on the antioxidant activity of glutathione peroxidase","volume":"116","author":"Iwaoka","year":"1994","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2016.07.021_bib36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1021\/ar100059g","article-title":"Functional mimics of glutathione peroxidase: bioinspired synthetic antioxidants","volume":"43","author":"Bhabak","year":"2010","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ejmech.2016.07.021_bib37","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/jo800381s","article-title":"Substituent effects upon the catalytic activity of aromatic cyclic seleninate esters and spirodioxyselenuranes that act as glutathione peroxidase mimetics","volume":"73","author":"Press","year":"2008","journal-title":"J.\u00a0Org. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416305694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523416305694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T21:25:21Z","timestamp":1589664321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523416305694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":40,"alternative-id":["S0223523416305694"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.07.021","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selenoureido-iminosugars: A new family of multitarget drugs","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2016.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}